table of content
1 Introduction to Research & Analysis Reports
1.1 Metagenomics in Healthcare Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metagenomics in Healthcare Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metagenomics in Healthcare Overall Market Size
2.1 Global Metagenomics in Healthcare Market Size: 2021 VS 2028
2.2 Global Metagenomics in Healthcare Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metagenomics in Healthcare Players in Global Market
3.2 Top Global Metagenomics in Healthcare Companies Ranked by Revenue
3.3 Global Metagenomics in Healthcare Revenue by Companies
3.4 Top 3 and Top 5 Metagenomics in Healthcare Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metagenomics in Healthcare Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metagenomics in Healthcare Players in Global Market
3.6.1 List of Global Tier 1 Metagenomics in Healthcare Companies
3.6.2 List of Global Tier 2 and Tier 3 Metagenomics in Healthcare Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metagenomics in Healthcare Market Size Markets, 2021 & 2028
4.1.2 Sample Extraction Kits
4.1.3 Metagenomics Kits
4.2 By Type - Global Metagenomics in Healthcare Revenue & Forecasts
4.2.1 By Type - Global Metagenomics in Healthcare Revenue, 2017-2022
4.2.2 By Type - Global Metagenomics in Healthcare Revenue, 2023-2028
4.2.3 By Type - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metagenomics in Healthcare Market Size, 2021 & 2028
5.1.2 Pharmaceutical Industries
5.1.3 Biotechnology Companies
5.1.4 Pathology Laboratories
5.1.5 Academic and Research Laboratories
5.1.6 Others
5.2 By Application - Global Metagenomics in Healthcare Revenue & Forecasts
5.2.1 By Application - Global Metagenomics in Healthcare Revenue, 2017-2022
5.2.2 By Application - Global Metagenomics in Healthcare Revenue, 2023-2028
5.2.3 By Application - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metagenomics in Healthcare Market Size, 2021 & 2028
6.2 By Region - Global Metagenomics in Healthcare Revenue & Forecasts
6.2.1 By Region - Global Metagenomics in Healthcare Revenue, 2017-2022
6.2.2 By Region - Global Metagenomics in Healthcare Revenue, 2023-2028
6.2.3 By Region - Global Metagenomics in Healthcare Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metagenomics in Healthcare Revenue, 2017-2028
6.3.2 US Metagenomics in Healthcare Market Size, 2017-2028
6.3.3 Canada Metagenomics in Healthcare Market Size, 2017-2028
6.3.4 Mexico Metagenomics in Healthcare Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metagenomics in Healthcare Revenue, 2017-2028
6.4.2 Germany Metagenomics in Healthcare Market Size, 2017-2028
6.4.3 France Metagenomics in Healthcare Market Size, 2017-2028
6.4.4 U.K. Metagenomics in Healthcare Market Size, 2017-2028
6.4.5 Italy Metagenomics in Healthcare Market Size, 2017-2028
6.4.6 Russia Metagenomics in Healthcare Market Size, 2017-2028
6.4.7 Nordic Countries Metagenomics in Healthcare Market Size, 2017-2028
6.4.8 Benelux Metagenomics in Healthcare Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metagenomics in Healthcare Revenue, 2017-2028
6.5.2 China Metagenomics in Healthcare Market Size, 2017-2028
6.5.3 Japan Metagenomics in Healthcare Market Size, 2017-2028
6.5.4 South Korea Metagenomics in Healthcare Market Size, 2017-2028
6.5.5 Southeast Asia Metagenomics in Healthcare Market Size, 2017-2028
6.5.6 India Metagenomics in Healthcare Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metagenomics in Healthcare Revenue, 2017-2028
6.6.2 Brazil Metagenomics in Healthcare Market Size, 2017-2028
6.6.3 Argentina Metagenomics in Healthcare Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metagenomics in Healthcare Revenue, 2017-2028
6.7.2 Turkey Metagenomics in Healthcare Market Size, 2017-2028
6.7.3 Israel Metagenomics in Healthcare Market Size, 2017-2028
6.7.4 Saudi Arabia Metagenomics in Healthcare Market Size, 2017-2028
6.7.5 UAE Metagenomics in Healthcare Market Size, 2017-2028
7 Players Profiles
7.1 Illumina
7.1.1 Illumina Corporate Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Metagenomics in Healthcare Major Product Offerings
7.1.4 Illumina Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.1.5 Illumina Key News
7.2 QIAGEN
7.2.1 QIAGEN Corporate Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Metagenomics in Healthcare Major Product Offerings
7.2.4 QIAGEN Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.2.5 QIAGEN Key News
7.3 PerkinElmer
7.3.1 PerkinElmer Corporate Summary
7.3.2 PerkinElmer Business Overview
7.3.3 PerkinElmer Metagenomics in Healthcare Major Product Offerings
7.3.4 PerkinElmer Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.3.5 PerkinElmer Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Major Product Offerings
7.4.4 Thermo Fisher Scientific Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Oxford Nanopore Technologies
7.5.1 Oxford Nanopore Technologies Corporate Summary
7.5.2 Oxford Nanopore Technologies Business Overview
7.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Major Product Offerings
7.5.4 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue in Global Market (2017-2022)
7.5.5 Oxford Nanopore Technologies Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
